Log In
BCIQ
Print this Print this
 

GC-072

  Manage Alerts
Collapse Summary General Information
Company Emergent BioSolutions Inc.
DescriptionAntibiotic
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationBacterial infection
Indication DetailsTreat bacterial infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$70.5M

$5.5M

$65.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/23/2015

$70.5M

$5.5M

$65.0M

Get a free BioCentury trial today